Sodium tetradecyl sulfate
| File:Tetradecylsulfate.png | |
| Systematic (IUPAC) name | |
|---|---|
|
Sodium tetradecylsulfate | |
| Clinical data | |
| Routes of administration | Intravenous injection |
| Legal status | |
| Legal status |
|
| Identifiers | |
| ATC code | C05BB04 (WHO) |
| PubChem | CID 14492 |
| Chemical data | |
| Formula | C14H29NaO4S |
| Molar mass | 316.43243 g/mol[[Script error: No such module "String".]] |
Sodium tetradecyl sulfate (STS) is a sclerosant drug. It is commonly used in the treatment of varicose and spider veins of the leg, during the procedure of sclerotherapy. Being a detergent-based chemical, its action is on the lipid molecules in the cells of the vein wall, causing destruction of the internal lining of the vein and eventual sclerosis of the vein. It is used in concentrations ranging from 0.1% to 3% for this purpose. In the UK, Ireland, Italy, Australia, New Zealand and South Africa, it is sold under the trade-name Fibro-Vein in concentrations of 0.2%, 0.5%, 1.0%, and 3%.[1]
As of 30th October, 2009, it has been claimed that it can also stop snoring when injected into the roof of the mouth by hardening the soft tissues which vibrate. [2]
References
Cite error: Invalid <references> tag;
parameter "group" is allowed only.
<references />, or <references group="..." />
| 30px | This drug article relating to the cardiovascular system is a stub. You can help ssf by expanding it. |
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Chemical articles without CAS Registry Number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Articles containing unverified chemical infoboxes
- 2Fix
- Organosulfates
- Cardiovascular system drug stubs
